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Abstract
Synaptic vesicle exocytosis mediating neurotransmitter release occurs 
spontaneously at low intraterminal calcium concentrations and is stimulated by a 
rise in intracellular calcium. Exocytosis is compensated for by the reformation of 
vesicles at plasma membrane and endosomes. Although the adaptor complex AP3 
was proposed to be involved in the formation of synaptic vesicles from endosomes, 
whether its function has an indirect effect on exocytosis remains unknown. Using 
mocha mice, which are deficient in functional AP3, we identify an AP3-dependent, 
tetanus neurotoxin-resistant, asynchronous release that can be evoked at 
hippocampal mossy fiber synapses. Presynaptic targeting of the tetanus 
neurotoxin-resistant vesicle SNARE TI-VAMP is lost in mocha hippocampal mossy 
fiber terminals while the localization of synaptobrevin 2 is unaffected. In addition, 
quantal release in mocha cultures is more frequent, and more sensitive to sucrose. 
We conclude that the lack of AP3 results in more constitutive secretion and the loss 
of an asynchronous evoked release component, suggesting an important function of 
AP3 in regulating SV exocytosis at mossy fiber terminals. 
3Introduction 
The release of neurotransmitter at the synapse requires the fusion and recycling of 
synaptic vesicles (SVs). The fusion of SVs with the plasma membrane depends on the 
formation of SNARE complexes between vesicle SNAREs and plasma membrane 
SNAREs, as demonstrated by the striking sensitivity of neurotransmitter release to 
clostiridial neurotoxins particularly Tetanus Neurotoxin (TeNT, for a review see (1)). 
Several models of the recycling of synaptic vesicles have been proposed: endosomal 
recycling, SV budding from the plasma membrane (2), kiss-and-run and kiss-and-stay 
(for a review see (3)). Endosomal recycling involves the molecular coat AP3 as 
suggested from experiments in neuroendocrine cells (4) but the importance of AP3 in 
neurotransmitter release is still unclear. AP3 is composed of four subunits and two 
different AP3 complexes are expressed in brain: the ubiquitous AP3A, composed of the 
į, ı3, ȕ3A and ȝ3A subunits, and the neuronal specific AP3B, composed of the į, ı3,
ȕ3B and ȝ3B subunits (5, 6). Mocha mice are deficient for the į subunit and therefore 
lack both AP3A and AP3B complexes. These mice have neurological disorders 
including hyperactivity and spontaneous seizures. In this paper, we set out to understand 
the importance of AP3 function in neurotransmitter release by characterizing basal and 
evoked release neurotransmitter release in mocha mice.  
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Results
Asynchronous release evoked at mossy fiber terminals is lost in mocha mice 
AP3 is particularly concentrated in the hilus and CA3 region of the hippocampus in 
heterozygous control (+/-) mice (Fig. S1a). Therefore, in order to assess the role of AP3 
in neurotransmitter release, we compared synaptic transmission at mossy fiber (MF)-
CA3 synapses in organotypic hippocampal cultures from mocha (-/-) and heterozygous 
control (+/-) littermates (Fig. 1a). We first examined Ca2+-dependent release evoked by 
MF stimulation. A stimulating electrode placed at the hilar border of the granule cell 
layer reliably evoked large post-synaptic currents (PSCs) that were specifically 
suppressed by the group 2 metabotropic glutamate receptor agonist DCG-IV (Fig. 1b; 
(7)). The amplitude of the PSCs gradually increased with stimulation intensities ranging 
from 15 to 600 V.μs. The correlation between the average charge of the PSCs and the 
stimulation intensity was not significantly different in cultures prepared from control vs. 
mocha mice (Fig. 1c). Cleavage of the SV SNARE synaptobrevin 2 (Syb2) by
preincubation of the cultures with tetanus neurotoxin (TeNT) for >72h caused a 
dramatic reduction in transmitter release evoked by MF stimulation. In cultures 
prepared from control mice, stimuli up to 2000 V.μs evoked small, unreliable PSCs, 
reminiscent of evoked transmission in cultured hippocampal neurons from Syb2 
knockout mice (8). Release at stimulated synapses was usually asynchronous and 
occurred within ~200 ms after stimulation with an average probability of 0.26±0.05 at 
the highest stimulation intensities (n=7). In contrast, no PSC could be evoked by MF 
stimulation in cultures prepared from mocha littermate mice.  
Loss of presynaptic TI-VAMP in mossy fiber terminals 
Our observations may reflect the contribution of a TeNT-insensitive, AP3-dependent 
pathway of transmitter release at MF terminals. We have previously shown that TI-
VAMP (i) is present at a high level in SVs at MF terminals (9), (ii) interacts with the į
subunit of the AP3 complex and (iii) is mistargeted in mocha fibroblasts (10). TI-
VAMP is therefore the best candidate v-SNARE to support TeNT-resistant vesicle 
exocytosis at MF terminals. Since TI-VAMP is not expressed at Schaffer collateral 
5terminals onto rat CA1 pyramidal cells ((9), Fig. S1a), we anticipated this form of 
exocytosis may not be observed at these synapses. Consistent with this prediction, 
evoked release was entirely impaired by TeNT at Schaffer collateral synapses onto CA1 
pyramidal cells in control mice (Fig. 1a,b). We therefore compared TI-VAMP 
localization in hippocampal sections from control and mocha mice. In the CA3 and 
dentate gyrus areas of control mice, TI-VAMP was localized in the MF terminals, as 
demonstrated by its colocalization with the presynaptic marker synaptophysin (Syp, Fig. 
2a, S1a). This was further confirmed in cultured granule cells because we found that 
67.20+/-6.65% of Syp positive punctae were also TI-VAMP positive (Fig. S2a). 
However in mocha sections, TI-VAMP labeling in MFs was completely lost (Fig. 2a, 
S1b). Thus, AP3 is required for the presynaptic targeting of TI-VAMP to MF terminals. 
In contrast, Syb2 localization was unchanged in brain sections from mocha mice as 
compared to control (Fig. 2b) suggesting that the presynaptic targeting of Syb2 is 
independent of AP3. Other SV proteins, including Rab3a, synaptotagmin 1, showed a 
presynaptic targeting similar in control and mocha mice (Fig. S1b, and our unpublished 
observations). Together, these results suggest that a form of TeNT-insensitive, AP3-
dependent, evoked release exists at MF-CA3 synapses, which likely involves TI-VAMP 
as a v-SNARE. 
TI-VAMP is blocked in the cell body of mocha neurons
We then examined the subcellular localization of TI-VAMP in mocha hippocampal 
granule cells from which mossy fibers originate. We found that TI-VAMP accumulated 
in the cell bodies of granule cells as shown by colocalization with VAMP4, a vesicular 
SNARE located in early endosomes (11, 12) and the TGN (13) (Fig. 2d). However, the 
AP-3 dependent sorting of TI-VAMP in the perinuclear VAMP4-positive compartment 
may not be specific to granule cells since a strong colocalization of TI-VAMP and 
VAMP4 was also found in the mocha CA3 pyramidal cells (Fig. 2c). The accumulation 
of TI-VAMP in cell bodies in mocha neurons was also observed in cultured 
hippocampal pyramidal neurons by immunolabeling (Fig. S2b) as well as immunogold 
labeling in ultrathin cryosections analyzed by electron microscopy (Fig. S2c). TI-
VAMP labeling in mocha neurons was found restricted to the cytosolic side of Golgi 
cisternea whereas in control pyramidal neurons TI-VAMP labeled vesicles and the 
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plasma membrane, consistent with its function as a secretory v-SNARE in control but 
not mocha neurons. Therefore, an AP-3 dependent sorting of TI-VAMP at the level of a 
VAMP4-positive perinuclear compartment is required for the proper targeting of TI-
VAMP.
 Increased basal release in mocha and BFA-treated mossy fiber terminals 
We then asked whether the lack of AP3 and TI-VAMP may impact Ca2+-independent,
constitutive release at MF terminals from mocha mice. Miniature EPSCs (mEPSCs) 
were recorded from CA3 pyramidal cells in slice cultures prepared from control and 
mocha littermates. In cultures from mocha mice, the frequency of mEPSCs was ~2-fold 
higher than in control cultures (3.22±0.55 vs. 1.66 ± 0.72 Hz, p<0.03, Fig. 3a). 
However, their mean amplitude was unchanged (19.44 ± 1.73 vs. 18.97 ± 3.32 pA, 
p=0.91) as were their rise time (10-90% of peak, 1.59 ± 0.09 vs. 1.45 ± 0.19 ms, 
p=0.32) and decay time constant (3.86 ± 0.12 vs. 3.37 ± 0.24 ms, p=0.14; Fig. 3b,c). 
These results suggest the lack of AP3 did not alter the rate of fusion pore opening or the 
number of postsynaptic receptors at excitatory synapses onto CA3 pyramidal cells. In 
addition, the higher mEPSC frequency in mocha cultures was not affected by the 
NMDA receptor antagonist APV (our unpublished observations), suggesting it did not 
reflect a greater activation of presynaptic NMDA receptors (14, 15) due to the lack of 
Zn release from MF terminals in mocha mice (16, 17). After 72h incubation with TeNT, 
mEPSC frequency in control cultures was reduced by ~84 % (to 0.27 ± 0.04 Hz, n=9; 
Fig. 3d), with no apparent change in their mean amplitude (19.18 ± 0.99 vs. 18.97 ±
3.32 pA, p=0.89), again consistent with observations in cultured hippocampal neurons 
from Syb2 knockout mice (8). In contrast, quantal release in mocha cultures was more 
resistant to TeNT and was reduced in frequency by only ~44 % (to 1.79 ± 0.56 Hz, 
n=8). These observations suggest the absence of AP3 not only increases Ca-independent 
quantal release but also reduces the effect of TeNT. Apart from TI-VAMP and Syb2, no 
other v-SNARE protein is known to be present at excitatory synapses on CA3 
pyramidal cells. Therefore, we analyzed the penetration and cleavage efficiency of 
TeNT in the slice cultures. We labeled TeNT-treated slice cultures with DAPI and 
antibodies against TeNT and SNAP-25. We found that TeNT penetrated throughout 
7mocha (Fig. 3e) as well as control explants (our unpublished observations). 
Furthermore, although the vast majority of Syb2 was cleaved in control and mocha
explants after 72h incubation with TeNT, a small fraction of Syb2 was still detected by 
western blotting. Quantification of the blots revealed twice as much TeNT-resistant 
Syb2 protein in mocha cultures as compared to control (Fig. 3f). Treatment with TeNT 
drastically reduced Syb2 labeling, but the remaining signal corresponded largely to 
Syb2 present at synapses, as revealed by colocalization with synaptophysin (Fig. 3g) 
thus the numerous TeNT-resistant mEPSCs observed in mocha are likely to be mediated 
by a presynaptic pool of Syb2 that resisted the treatment with TeNT. 
Newly formed vesicles derived from endosomes disappear with a half-life of ~36 min 
after treatment with the fungal drug Brefeldin A (BFA)  which specifically targets the 
AP3-dependent pathway in PC12 cells (4, 18-20). In order to test the effect of acute 
inactivation of the AP3 pathway, we therefore incubated control hippocampal slices 
with BFA for ~2-4 hours. In BFA-treated slices, mEPSC frequency was increased by 
~127 % as compared to control (2.59 ± 0.33 vs. 1.14 ± 0.25 Hz, n=14 and 12 cells, 
respectively, p<0.005, Fig. S4a-c). The ratio of synaptic TI-VAMP/synaptic Syp 
measured by immunolabeling was not significantly altered by BFA neither in the hilus 
nor in the st. lucidum (Fig. S4d). This is consistent with the fact that longer times may 
be required to clear TI-VAMP from MF terminals and demonstrate that the mocha
phenotype can be reproduced by acute pharmacological inactivation of AP3-dependent 
SV formation. 
 Increased sensitivity of release to osmotic stimulation in mocha MF terminals 
Syb2 is resistant to TeNT (21) in SNARE complexes (21) that may be clamped by 
complexin and synaptotagmin before calcium rise (22). TeNT-resistant Syb2 was 
associated with release-competent SVs (23, 24). Our previous results could suggest that 
the lack of AP3 and TI-VAMP in MF SVs may thus increase the capacity of Syb2 to 
form TeNT-resistant clamped SNARE complexes thereby enhancing the probability of 
calcium-independent fusion at mocha MF terminals. In order to test this hypothesis, we 
examined the rate of release induced by focal application of a hypertonic solution 
because previous studies showed that hypertonic solution specifically recruits readily 
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releasable quanta at hippocampal synapses (25) and stimulates secretion in a calcium 
independent manner. We thus compared the effects of focal applications of a 0.5 M 
sucrose solution through a patch pipette positioned in st. lucidum ~25 μm away from 
the somata of the recorded pyramidal cells. Since effective sucrose concentration at 
release sites may be difficult to control in slice cultures, we used varying injection 
pressures to compare the sucrose sensitivity of release in mocha vs. control cultures. In 
cells recorded from control cultures, application of sucrose with low pressure (0.25 psi) 
caused a ~2-fold increase in mEPSC frequency, whereas at a higher pressure (1.5 psi), a 
further ~7-fold increase was observed (Fig. 4a, b, c). The sensitivity of the release rate 
to sucrose was significantly increased in recordings from mocha cultures: even low 
pressure application of sucrose caused a ~9-fold increase in mEPSC frequency, which 
was further enhanced by another ~35 % at high pressure (Fig. 4a, b, c). Interestingly 
however, recruitment of readily releasable vesicles by sucrose was disrupted in both 
control and mocha cultures by prior incubation with TeNT, and application of 
hypertonic solution failed to produce an increase in mEPSC frequency even at high 
pressure (Fig. 4a, b). Taken together, these results suggest that an AP3-dependent 
mechanism decreases the sucrose sensitivity of constitutive secretion.  
9Discussion
Mocha mice are deficient for AP3į subunit and therefore lack both ubiquitous 
AP3A and neuronal AP3B complexes. Here, we have shown that presynaptic TI-
VAMP, a well-established AP-3 į cargo (10, 26), is lost in mocha CA3 MFs. Other AP-
3 cargos including the zinc transporter ZnT-3 (16, 17), the chloride channel ClC-3 (27), 
and the phosphatidylinositol-4-kinase type IIα (28) are mislocalized in mocha CA3 
MFs. A previous study in ZnT3 knock out mice showed the lack of vesicular zinc in 
MFs does not significantly affect the MF-associated excitability of CA3 pyramidal cells 
(29). In addition, we observed that the higher mEPSC frequency in mocha cultures was 
not affected by blocking NMDA receptors, further suggesting that the lack of Zn release 
from MF terminals in mocha mice does not explain the phenotype we observed. 
Similarly, the lack of MF ClC-3 is unlikely to explain the increased quantal release from 
mocha MF terminals mice. The loss of CIC-3 rather affects acidification of SVs 
resulting in a slight reduction of quantal size (30). Finally, recent data suggested AP3 
may regulate the volume of large dense-core vesicles in chromaffin cells (31). This 
however is unlikely to apply to MF terminals since i) we did not observe any change in 
quantal size in mocha cultures and ii) the pathway of SV reformation largely differs 
from that of secretory granules, the latter maturing via the removal of material from 
immature secretory granules. Treatment of hippocampal slice cultures with TeNT 
revealed an asynchronous component of secretion evoked in CA3 pyramidal cells by 
single stimulation of mossy fibers. This asynchronous release is unlikely to be mediated 
by the low amount of TeNT-resistant Syb2 since it was not observed in mocha cultures 
which showed more TeNT-resistant Syb2. Furthermore, this asynchronous component 
was observed at MF-CA3 synapses but not at CA1-CA3 synapses, where TI-VAMP is 
not expressed. Since no other TeNT-resistant v-SNARE was ever detected at MF 
terminals, we suggest TI-VAMP likely mediates the asynchronous evoked release 
unraveled in our experiments. In conclusion, although we cannot exclude that other AP3 
cargos lost in mocha MF terminals may participate to the mocha phenotype, the loss of 
TI-VAMP seems most likely to explain the perturbation of evoked SV release described 
in the present study.
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Asynchronous release was not observed in TeNT-untreated explants, suggesting 
inactivation of Syb2 may be required for the expression of this asynchronous evoked 
release. This observation strongly suggests TI-VAMP and Syb2 may both be present 
on the same rather than distinct SVs. Consistent with this scenario, Syb2 was shown to 
have a higher rate of SNARE complex assembly than TI-VAMP both in vitro and in
vivo (10), predicting that evoked release mediated by TI-VAMP would be detected 
only after cleavage of Syb2. In addition, cleavage of Syb2 by TeNT was shown to 
modify the coupling of intracellular calcium and release-competent vesicles (32) 
suggesting that removal of TeNT-sensitive v-SNAREs allows for the expression of a 
secretory machinery that may be hard to observe otherwise.  Interestingly, Sr+
preferentially stimulates asynchronous release (33) and different synaptotagmin 
isoforms show different sensitivities to Ca2+ and Sr+ (34). For instance, Synaptotagmin 
1 and 7 have different sensitivities to calcium (35), the latter interacting with TI-
VAMP in fibroblasts (36) and showing biochemical properties suitable for a Ca2+
sensor for asynchronous release (35, 37, 38). Therefore, we speculate that MF SVs 
may be equipped with two distinct fusion machineries for exocytosis, one depending 
on Syb2 and the other on TI-VAMP as a v-SNARE, which may be recruited in 
different conditions. 
 We have shown a higher basal, calcium-independent release in mocha cultures, 
with no apparent change in quantal size or current kinetics. This observation strongly 
argues for a presynaptic difference between control and mocha MF-CA3 synapses. This 
likely not due to a greater density of MF terminals onto mocha CA3 pyramidal cells 
because of axonal sprouting induced in organotypic cultures (39) or a greater 
contribution of recurrent CA3-CA3 synapses to miniature EPSCs in mocha cultures. 
Indeed, we found an equal Syp staining in control and mocha brain sections and the 
increased quantal release was also observed upon pharmacological disruption of AP3 by 
BFA in acute hippocampal slices. In addition, quantal release evoked by hyperosmotic 
solution directly applied onto MF terminals was also increased in mocha cultures. 
Therefore, the most likely explanation is that more vesicles are ready-to-fuse due to the 
absence of AP3 and possibly TI-VAMP in mocha vs. control MF terminals. Since BFA 
specifically impairs the AP3-dependent formation of new vesicles from endosomes our 
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results suggest that AP3-dependent, newly-formed vesicles have a reduced capacity to 
fuse. How AP3-dependent sorting may decrease basal release remains to be explored.  
In conclusion, our data suggest that the molecular mechanism of transmitter 
release at MF terminals reaches a high degree of complexity with at least two exocytic 
SV-SNAREs: Syb2 and TI-VAMP. AP3 function is important for both constitutive as 
well as evoked release, raising the possibility that specific forms of synaptic plasticity 
might occur at terminals expressing AP3 cargos like TI-VAMP (9).
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Materials and methods 
Animals
Heterozygous mocha mice were originally obtained from M. Robinson (CIMR, 
Cambridge) and then bred in-house. The experiments were carried out in accordance 
with the European Communities Council Directive of 24 November 1986 
(86/609/EEC). All efforts were made to minimize the number of animals used and their 
suffering.
Immunofluorescence  
Mocha and control (heterozygous littermates) 1-2 months old mice were anaesthetized 
with 35% chloral hydrate or pentobarbital and perfused through the heart with 
paraformaldehyde 4%. The dissected brains were fixed overnight in 4% 
paraformaldehyde in phosphate buffered saline and cut on a vibratome to 30ȝm thick 
sections and processed for immunofluorescence as described previously (9). Confocal 
laser-scanning microscopy was performed using a SP2 confocal microscope (Leica 
Microsystems, Mannheim, FRG). Images were assembled using Adobe Photoshop 
(Adobe Systems, San Jose, CA, USA).  
 Western Blotting 
SDS-PAGE analysis was performed using 4-12% NuPAGE (Invitrogen, France) 
gradient gels and the manufacturer’s buffers and then processed for Western blotting. 
Blots were quantified using ImageJ (NIH, Maryland) and statistical significance was 
estimated using Mann-Whitney rank sum tests performed under SigmaStat (SPSS Inc.)  
Electrophysiological recordings 
Organotypic hippocampal slices from 6 days old mice were maintained in culture as 
described previously (40, 41). After 2-3 days, cultures were preincubated 24 hours in 
serum-free medium and then grown another 3-4 days in fresh serum-free medium 
containing TeNT (500 ng/ml) or not. Electrophysiological recordings were carried out 
as described in supplementary methods. For mossy fiber stimulation, the stimulating 
electrode was positioned at the hilar border of the granule cell layer. For Schaffer 
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collateral stimulation, a cut was made between areas CA3 and CA1 and the electrode 
was positioned in stratum radiatum ~50-100 μm apart from the recorded cell.  
Values are expressed as mean±SEM. Statistical significance was estimated using Mann-
Whitney or Wilcoxon rank sum tests, or two-way ANOVA performed under SigmaStat 
(SPSS Inc.). 
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Figure legends 
Fig.1
Evoked synaptic transmission in slice cultures prepared from control and mocha mice.  
(a) Postsynaptic currents evoked in CA3 pyramidal cells by MF stimulation. 10 
superimposed sample traces are shown for maximal stimulation intensity. Top: control 
cultures. Bottom: cultures treated for at least 72 hours with TeNT (500 ng/ml). After 
TeNT treatment unreliable, asynchronous responses (marked with a tick) can be 
detected in control (+/-) but not mocha (-/-) cultures. EPSCs evoked by Schaffer 
collateral stimulation in CA1 cells are also completely abolished by prior incubation 
with TeNT. (b) Stimulation arrangement: mossy fibers (MF) were stimulated with a 
patch pipette located at the hilar border of the granule cell layer (MF stim.). 
Associational/commissural fibers (A/C) were stimulated in st. oriens. Responses to 
either stimulation were distinguishable by their sensitivity to DCG-IV (1μM). (c) 
Comparison of responses (integrated over 200ms of the stimulus artifact) evoked by 
increasing MF stimulations in control vs. mocha cultures or by SC stimulation in CA1 
cells. Left: in control cultures, no significant difference could be detected between 
control (filled circles) and mocha CA3 cells (open circles, n=4 and 7 cells, respectively; 
Two way ANOVA p>0.05). Right: after treatment with TeNT, responses were evoked 
in control CA3 cells (filled triangles) but not in mocha CA3 (open triangles) or control 
CA1 cells (filled squares, n=7, 11 and 5 cells, respectively; Two way ANOVA, p<0.02 
for control CA3 vs. mocha CA3 or control CA1 and p>0.05 for mocha CA3 vs. control 
CA1).
Fig. 2 
TI-VAMP is absent from MF terminals and accumulates in the cell body of mocha
neurons.
50 μm vibratome sections from adult control (+/-) and mocha (-/-) mice were labeled 
with DAPI (blue) and monoclonal antibodies against TI-VAMP or Syb2, polyclonal 
antibodies against Syp or VAMP4. 
(a) TI-VAMP is lost from the terminals of granule cells (mossy synapses) innervating 
CA3 pyramidal cells in mocha brain. A dense signal for Syp (green) is detected 
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throughout the CA3 region in stratum oriens (so), stratum pyramidale (sp) and stratum 
radiatum (sr) in control (+/-) hippocampus. The strong immunofluorescence presented 
in the stratum lucidum (sluc), correspond to MF terminals innervating CA3 pyramidal 
dendrites. Lower panels are magnification of the boxed windows. In control (+/-) mice, 
confocal images shows that TI-VAMP (red) immunoreactivity colocalizes in mossy 
synapses with Syp puncta in sluc. However in mocha (-/-) mice, TI-VAMP is not 
detected in presynaptic terminals (sluc) of granule cells, while a faint 
immunofluorescence is detected in pyramidal cell soma (boxed window in a and c). (b). 
Syb2 localization is unaffected in the mocha hippocampus. As for Syp 
immunoreactivity, Syb2 is detected in control and mocha mice throughout so, sp, sluc 
and sr.  (c, d). TI-VAMP is mislocalized in the granule cells of mocha mice. In control 
mice, TIVAMP is present in MF both in the lucidum (c) and in the hilus of the dentate 
gyrus (d). In mocha mice, the strong labeling of the lucidum and hilus in the dentate 
gyrus is not present. Double labeling of TIVAMP and VAMP4 shows that the 
remaining TIVAMP colocalizes with VAMP4 in the cell bodies of pyramidal (sp) and 
granule cells (stratum granulosum, sg, boxed windows). Bar: 100 μm. 
Fig. 3 
Ca-independent, quantal release at excitatory synapses on CA3 cells in control and 
mocha cultured slices.
(a) Representative traces of miniature EPSCs (mEPSCs) recorded in CA3 pyramidal 
cells from control (+/-) and mocha (-/-) cultures, treated or not with TeNT. (b) Averaged 
mEPSCs (~100) detected from the above recordings. Black traces: control. Blue traces: 
after TeNT treatment. No difference in either their rate of onset or decay was apparent. 
(c) Left: average amplitude of mEPSCs recorded in all four conditions. No significant 
difference was observed (n=7, 9, 11 and 8 cells, respectively. p>0.05). Right: 
cumulative amplitude histograms from the same four datasets. The distributions were 
not significantly different (Kolmogorov-Smirnov test, p>0.05). (d) Mean frequencies of 
mEPSCs were significantly different between control and TeNT-treated cultures in both 
control and mocha cultures (p<0.005 and p<0.05 respectively). mEPSC frequency was 
also different in control vs. mocha culture in the absence of TeNT (p<0.05). (e) Mocha
culture slices treated with TeNT for 72 h were fixed and labeled with antibodies against 
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SNAP25 (red), TeNT (green), and DAPI (blue). The whole surface of the explant can be 
visualized either by DAPI (nucleus) or by SNAP25 (neuronal plasma membrane). Note 
that the TeNT staining is uniformly distributed confirming the extended penetration of 
the toxin. Scale bar: 200 μm. (f) Culture slices used in electrophysiological recordings 
were lysed and analyzed by Western blotting with antibodies against AP3į, Syb2, and 
actin (as a loading control). 72 h treatment with TeNT resulted in efficient cleavage of 
Syb2 although quantification of the remaining Syb2 revealed a two-fold increase in 
TeNT-resistant Syb2 in mocha slices (mean ± SEM: control 17.83 ± 2.35 n=6, mocha 
37.58 ± 6.31 n=6, p<0.015 (Mann-Whitney rank sum test)). (g) Mocha cultured slices 
treated with or without TeNT for 72 h were fixed and labeled with antibodies against 
Synaptophysin (green), Synaptobrevin2 (red), and DAPI (blue). Note that the remaining 
Syb2 labeling after TeNT treatment is very faint. The rare remaining Syb2 puncta are 
mainly synaptic. Bar: 50 μm. 
Fig. 4 
Differential recruitment of readily releasable vesicles by hypertonic sucrose applications 
in control vs. mocha cultured slices.
 (a) Sample traces from individual recordings of mEPSCs recorded in the presence of 
tetrodotoxin and an external Ca/Mg ratio of 0.1 before and during application of a 500 
mOsm sucrose solution in the presence of a 2.5 ml/min normal ACSF perfusion. High 
sucrose was applied by pressure injection through a patch pipette to the proximal 
dendrites of the recorded cell in st. lucidum. Low sucrose: ~0.25 psi. High sucrose: 1.5 
psi. (b) Average frequency of mEPSCs recorded in all conditions. The sensitivity of 
mEPSC frequency to sucrose was significantly different in control vs. mocha cultures 
(n=4 and 6 cells, respectively; Two way ANOVA p<0.01). After treatment with TeNT, 
sucrose application failed to increase mEPSC frequency (n=9 and 7 cells, respectively). 
(c) Frequencies were normalized to control values, showing a greater relative increase 
in mocha (open bars) compared to control slices (filled bars) upon low-pressure (Mann-
Whitney  p<0.05) but not high-pressure application of sucrose (p=0.5).

Supplemental Results 
Late onset of AP-3 expression explains normal mocha brain development 
Our previous studies demonstrated that TI-VAMP is critical for neurite outgrowth (1, 2). Although 
brain development of the mocha mice seemed normal (3), such a defect may impair hippocampal 
connectivity and therefore complicate the interpretation of our present results. We thus examined TI-
VAMP localization and neuritogenesis in control and mocha neurons (Fig. S3a, b). Both neurite 
outgrowth and TI-VAMP localization to the growth cone were normal in hippocampal neurons 
cultured 3div from mocha mice (Fig. S3a, b), demonstrating that TI-VAMP is transported to the 
growth cone in an AP3-independent manner. The lack of function of AP3 in neuritogenesis is further 
supported by the developmental regulation of its expression. In neurons growing in culture, AP3-į
expression was greatly increased at 7 days in vitro and reached a peak at ~14 days (Fig. S3c). These 
results are thus consistent both with the essential role for TI-VAMP in neurite outgrowth and with the 
fact that brain development appears normal in mocha mice, suggesting a role of AP3 in SV recycling 
rather than neurite outgrowth. 
Supplemental Material and Methods 
Antibodies and Reagents 
The mouse monoclonal antibody (clone 158.2; (4) and rabbit polyclonal antibody directed against TI-
VAMP (TG18; (5), the rabbit polyclonal antibodies anti-synaptophysin (MC1; (6)), anti-VAMP4 
(TG19; (7)) and anti-SNAP-25 (MC9; (8)) have been described previously. Mouse monoclonal 
antibodies against Syb2 (clone 69.1), Rab3a (clone 42.2) and Synaptotagmin 1 (clone 41.1) were 
generous gifts from R. Jahn (Max Planck Institute, Goettingen, FRG). Monoclonal antibody against 
TeNT has been described previously (9). Monoclonal anti-AP3į antibody (SA4) was from the 
Developmental Studies Hybridoma Bank (University of Iowa, Iowa City, Iowa).  Chicken polyclonal 
antibody against MAP2 (ab5392) was from AbCam (Milton Road, Cambridge, UK). Affinity-purified 
horseradish peroxidase-, Cy3- and Cy5-coupled biotin-coupled goat anti-rabbit and anti-mouse 
immunoglobulins were from Jackson ImmunoResearch (West Grove, PA, USA). Alexa 488- and 
Alexa 594-coupled goat anti-rabbit and anti-mouse immunoglobulins and Alexa 568-coupled 
phalloidin were from Molecular Probes (Carlsbad, CA). Tetanus neurotoxin was isolated and 
characterized as previously described (10).  
Neuronal Cell Culture and Immunocytochemistry 
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Hippocampal neurons from newborn (P0-P1) mice were prepared as described previously (11)  and 
grown on poly-L-Lysine-coated (Sigma-Aldrich, France) 14mm coverslips at a density of 25,000-
50,000 per coverslip in Neurobasal media supplemented with B27 (GIBCO, Invitrogen France) and 
Cytosine ȕ-D-arabinofuranoside (Sigma-Aldrich, France).  Granule cells were obtained from dissected 
dentate gyrus of postnatal mice (P5) (12, 13) and grown on poly-Ornithine-coated (Sigma-Aldrich, 
France) per 14mm coverslips at a density of 250,000 per coverslip in Neurobasal media supplemented 
with B27 (GIBCO, Invitrogen France), 2mM Glutamine, 25% horse serum for the first 5div, 10% 
thereafter.  Neurons in culture were fixed with 4% paraformaldehyde/ 4% sucrose and processed for 
immunofluorescence microscopy as described previously (5).
Electrophysiological recordings 
For recording, cultures were transferred to a submerged chamber mounted on an upright microscope 
and superfused at a rate of ~2.5 ml/min with ACSF containing (in mM): NaCl, 124, NaHCO3, 26.2, D-
glucose, 11, KCl, 2.5, NaH2PO4, 1, CaCl2, 4 and MgCl2, 4. Whole-cell recordings from CA3 or CA1 
pyramidal cells were made using patch electrodes (3-5 M: resistance) made from borosilicate glass 
capillaries (Hilgenberg, Germany) and filled with internal solution containing (in mM): CsCH3SO3,
110, CsCl, 20, HEPES, 10, EGTA, 10, MgATP, 4, Na3GTP, 0.4, MgCl2, 1.8. 
Postsynaptic currents were evoked at 0.1 Hz using extracellular stimulation through a borosilicate 
microelectrode filled with ACSF and recorded from cells held at -60 mV using an Axopatch 1D 
amplifier and digitized at 20 kHz using Clampex software of the pClamp 9 suite (Axon Instruments, 
USA). PSC amplitude and access resistance were monitored online. PSCs were then measured offline 
using Clampex software. Currents were integrated over a 200 ms time window set immediately after 
the stimulus artifact (C200). In order to correct evoked PSC charge for spontaneous PSCs, baseline 
currents were also integrated from a 50 ms pre-stimulus period and the corrected charge was 
calculated as Ccorr = C200 - 4 x C50.
Miniature EPSCs were recorded in modified ACSF in which CaCl2 and MgCl2 concentrations were 
adjusted to 0.5 and 4.5 mM, respectively, in the presence of tetrodotoxin (TTX, 2 μM, Latoxan, 
France) and bicuculline methochloride (20 μM, Fisher Bioblock Scientific, France). For focal 
application of a hypertonic solution, a second patch pipette filled with 0.5M sucrose in ACSF was 
positioned in st. lucidum ~40-50 μm apart from the recorded cell and connected to a PicoSpritzer 
device (General Valve, Fairfield, NJ, USA). Miniature EPSCs were detected using Detectivent 
software written under LabView (kindly provided by N. Ankri, INSERM U641, Marseille, France). 
In some experiments, acute hippocampal slices were prepared from 12-14 days old pups as described 
(14). Slices were kept ~1 hour in normal ACSF equilibrated with a 95% O2 / 5% CO2 mixture. Half of 
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the slices were then exposed to 10μg/ml brefeldin A (Sigma, France) for an additional 2 hours whereas 
the other half was kept in ACSF until recordings were started. 
Electron Microscopy 
Neurons from control or mocha mice were fixed with 2% (w/v) PFA or with a mixture of 2% (w/v) 
PFA and 0.2% (w/v) glutaraldehyde in 0.1 M Phosphate Buffer (PB) pH 7.4. Cells were processed for 
ultracryomicrotomy as described (15). Ultrathin sections were prepared with an Ultracut FCS 
ultracryomicrotome (Leica, Wien, Austria), and single immunogold labeled with antibodies and 
protein A coupled to 10 or 15 nm gold (PAG 10 and PAG 15).  Sections were observed and 
photographed under a Philips CM120 Electron Microscope (FEI Company, Eindoven, The 
Netherlands). Digital acquisitions were made with a numeric Keen View camera (Soft Imaging 
System, Germany).  
Neurite outgrowth measurements 
Neurons were fixed at 1 div, labeled with Alexa-568-coupled phalloidin, and imaged with a MicroMax 
CCD camera (Princeton Instruments, Princeton, NJ). Neurite length was measured using Metamorph 
software (Princeton Instruments). 
Supplemental Figures 
Supplemental Figure 1: TIVAMP and synaptic proteins localization in the whole hippocampus 
of control and mocha mice. 
a. AP3į (red) is expressed in the hilus in the dentate gyrus (DG) and in stratum lucidum in CA3 region 
of control (+/-) mice but not in mocha (-/-) mice. b. TIVAMP (red) is mainly expressed by granule 
cells in presynaptic terminals of the hilus in the dentate gyrus and in stratum lucidum in CA3 region 
and faint or absent in pyramidal terminals of the CA1 region in control (+/-) mice. TIVAMP 
expression shows a strikingly different pattern in mocha (-/-) mice. Syp immunoreactivity (green) is 
similar in both mice.  The nuclei are labeled with DAPI (blue). Scale bar: 200 μm. The boxed region 
corresponds to the field seen in figure 1 at high magnification. c. Distribution patterns of synaptic 
vesicle proteins were assayed in control and mocha mice. No major default was noticed for Syb2, and 
Rab3a (red) immunoreactivities between the two populations of mice. 
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Supplemental Figure 2: TI-VAMP concentrates in synapses in cultured granule cells and 
accumulates in the Golgi of mature mocha pyramidal neurons. 
(a) Granule cells (21div) from control mice were colabeled with antibodies against TI-VAMP, Syp, 
and MAP2.  TI-VAMP colocalizes with Syp (67.20+/-6.65% of Syp positive punctae are also TI-
VAMP positive, 10 cells, 1282 synapses), suggesting that it is present in a large subset of synaptic 
terminals. Post-synaptic neurons contacted by Syp+ terminals (neuron, n) were identified on the basis 
of the MAP2 staining to exclude astroglial (glial, g) staining of TI-VAMP. (b) Hippocampal neurons 
(14 div) cultured from control (+/-) or mocha (-/-) mice were colabeled with antibodies against TI-
VAMP and antibodies against VAMP4. In mocha neurons TI-VAMP accumulates in the Golgi where 
it colocalizes with VAMP4. Bar: 10μm. (c) Ultrathin cryosections of mature cultured hippocampal 
neurons (14 div) from control or mocha mice were immunogold labeled with polyclonal antibodies 
against TI-VAMP. In control (+/-) neurons, TI-VAMP is present on vesicles and tubules throughout 
the soma and occasionally present at the plasma membrane, while in mocha (-/-) neurons TI-VAMP 
labeling is mainly found associated with the Golgi apparatus (GA). 
Supplemental Figure 3: Neurite outgrowth and TI-VAMP localization to the growth cone are 
unaffected in mocha neurons. (a) Immature hippocampal neurons (3 div) cultured from control (+/-) 
or mocha (-/-) newborn mice were labeled for TI-VAMP and analyzed by confocal microscopy. In 
both control and mocha neurons, TI-VAMP labeling is present in the growth cone. Bar: 10μm (b) 
Hippocampal neurons from control (+/-) and mocha (-/-) mice were grown for 1 div and their neurite 
length was measured. No difference in neurite outgrowth was observed between control and mocha
neurons (Bars represent SEM; n=100 neurons from two independent experiments). (c) Hippocampal 
neurons growing in culture were lysed at different stages in development and TI-VAMP and AP3 
expression were analyzed by Western blotting. An equal quantity of protein was loaded in each lane. 
Note that both TI-VAMP and AP3 expression are upregulated during development. 
Supplemental Figure 4: Increased quantal release at MF terminals after acute disruption of AP3 
by Brefeldin A.
(a) Sample traces from individual recordings of mEPSCs recorded from CA3 pyramidal cells in acute 
hippocampal slices (P10-12). Prior to recording, slices were incubated for > 2 hours in either normal 
ACSF or ACSF containing 10μM Brefeldin A. In Brefeldin-treated slices, mEPSC frequency was 
increased by ~127 % as compared to control (2.59 ± 0.33 vs. 1.14 ± 0.25 Hz, n=14 and 12 cells, 
respectively, p<0.005). (b) Scaled and averaged mEPSCs (~100) detected from the recordings shown 
in (a). Black traces: control. Blue traces: Brefeldin A. No difference in either their rate of onset or 
decay was apparent. (c) Summary data from all recordings. (d) Ratio of TI-VAMP:Syp fluorescence 
intensity in control and BFA-treated slices in the hilus and str.lucidum (mean+/-sem, n=14 slices). 
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